Xylocaine 5% W/ Glucose 7.5%

   
Google
 
Web NewDrugInformation.com

Xylocaine 5% W/ Glucose 7.5%


Drug - Xylocaine 5% W/ Glucose 7.5%
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; SPINAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Lidocaine Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 5%
The potency of the active ingredient(s), Lidocaine Hydrochloride. May repeat for multiple part products.

Applicant - ASTRAZENECA
The firm name holding legal responsibility for Xylocaine 5% W/ Glucose 7.5%. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 010496
The FDA assigned number to Xylocaine 5% W/ Glucose 7.5%. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Xylocaine 5% W/ Glucose 7.5%. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jul 7, 1982
The date Xylocaine 5% W/ Glucose 7.5% was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Xylocaine 5% W/ Glucose 7.5%. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Xylocaine 5% W/ Glucose 7.5% is in. Format is RX, OTC, DISCN.

Applicant Full Name - Astrazeneca Lp
The full name of the firm holding legal responsibility for the new application of Xylocaine 5% W/ Glucose 7.5%.

Xylocaine 5% W/ Glucose 7.5%